Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Regenerative Medicine | 10 | 2025 | 313 | 3.610 |
Why?
|
Muscle, Skeletal | 30 | 2024 | 4978 | 2.940 |
Why?
|
Rehabilitation | 4 | 2020 | 129 | 1.810 |
Why?
|
Osteoarthritis, Knee | 6 | 2025 | 1251 | 1.510 |
Why?
|
Extracellular Matrix | 9 | 2025 | 1739 | 1.510 |
Why?
|
Osteoarthritis | 3 | 2025 | 1072 | 1.500 |
Why?
|
Myoblasts | 8 | 2020 | 234 | 1.430 |
Why?
|
Glucuronidase | 3 | 2021 | 205 | 1.390 |
Why?
|
Aging | 13 | 2024 | 8744 | 1.370 |
Why?
|
Stem Cells | 11 | 2024 | 3537 | 1.240 |
Why?
|
Regeneration | 16 | 2023 | 1524 | 1.180 |
Why?
|
Menopause | 2 | 2025 | 1656 | 1.040 |
Why?
|
Arsenic | 6 | 2023 | 358 | 0.980 |
Why?
|
Muscle Development | 7 | 2020 | 258 | 0.970 |
Why?
|
Complement C4b | 1 | 2023 | 124 | 0.820 |
Why?
|
Physical Conditioning, Animal | 3 | 2017 | 363 | 0.800 |
Why?
|
Muscular Dystrophy, Animal | 3 | 2013 | 89 | 0.800 |
Why?
|
Satellite Cells, Skeletal Muscle | 2 | 2016 | 124 | 0.760 |
Why?
|
Cartilage Diseases | 1 | 2023 | 160 | 0.740 |
Why?
|
Stem Cell Transplantation | 5 | 2021 | 1596 | 0.710 |
Why?
|
Progesterone | 1 | 2025 | 752 | 0.700 |
Why?
|
Musculoskeletal Diseases | 3 | 2017 | 599 | 0.680 |
Why?
|
Platelet-Rich Plasma | 1 | 2022 | 180 | 0.680 |
Why?
|
Cartilage, Articular | 2 | 2025 | 1104 | 0.640 |
Why?
|
Guided Tissue Regeneration | 2 | 2016 | 86 | 0.620 |
Why?
|
Cues | 1 | 2023 | 878 | 0.610 |
Why?
|
Muscle Contraction | 5 | 2023 | 1209 | 0.590 |
Why?
|
Estradiol | 1 | 2025 | 1951 | 0.570 |
Why?
|
Mice, Inbred C57BL | 13 | 2025 | 22381 | 0.560 |
Why?
|
Muscular Diseases | 3 | 2023 | 553 | 0.550 |
Why?
|
Resistance Training | 3 | 2024 | 198 | 0.550 |
Why?
|
Biophysics | 1 | 2018 | 379 | 0.540 |
Why?
|
Electric Stimulation Therapy | 2 | 2013 | 635 | 0.530 |
Why?
|
Muscle Fibers, Skeletal | 5 | 2023 | 553 | 0.530 |
Why?
|
Sarcopenia | 1 | 2021 | 378 | 0.510 |
Why?
|
Exercise | 6 | 2024 | 5955 | 0.500 |
Why?
|
Spinal Cord Injuries | 4 | 2013 | 928 | 0.500 |
Why?
|
Periodicals as Topic | 2 | 2024 | 1465 | 0.490 |
Why?
|
Tissue Scaffolds | 4 | 2016 | 950 | 0.480 |
Why?
|
Wheelchairs | 2 | 2005 | 78 | 0.470 |
Why?
|
Neural Conduction | 1 | 2015 | 443 | 0.460 |
Why?
|
Fibroblasts | 4 | 2021 | 4176 | 0.450 |
Why?
|
Chondrocytes | 3 | 2025 | 800 | 0.450 |
Why?
|
Animals | 43 | 2025 | 169222 | 0.440 |
Why?
|
Myofibrils | 1 | 2014 | 143 | 0.440 |
Why?
|
Models, Animal | 3 | 2017 | 2120 | 0.430 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 872 | 0.430 |
Why?
|
Professional Role | 1 | 2016 | 315 | 0.420 |
Why?
|
Neuromuscular Junction | 2 | 2013 | 407 | 0.420 |
Why?
|
Myoblasts, Skeletal | 1 | 2013 | 74 | 0.410 |
Why?
|
Collagen Type II | 2 | 2023 | 151 | 0.400 |
Why?
|
Mitochondria | 4 | 2020 | 3681 | 0.380 |
Why?
|
Longevity | 1 | 2019 | 1078 | 0.370 |
Why?
|
Mice | 28 | 2025 | 82024 | 0.370 |
Why?
|
Military Medicine | 1 | 2013 | 185 | 0.360 |
Why?
|
Electromyography | 1 | 2015 | 1399 | 0.350 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2819 | 0.320 |
Why?
|
Muscle Strength | 4 | 2021 | 640 | 0.320 |
Why?
|
Cell Differentiation | 11 | 2024 | 11665 | 0.310 |
Why?
|
Exercise Therapy | 2 | 2014 | 939 | 0.300 |
Why?
|
Dystrophin | 1 | 2009 | 284 | 0.290 |
Why?
|
Exosomes | 2 | 2022 | 422 | 0.280 |
Why?
|
Energy Metabolism | 2 | 2018 | 2908 | 0.280 |
Why?
|
NF-kappa B | 1 | 2016 | 2493 | 0.280 |
Why?
|
Wound Healing | 4 | 2017 | 2808 | 0.270 |
Why?
|
Nervous System Diseases | 1 | 2017 | 1661 | 0.270 |
Why?
|
Self-Help Devices | 1 | 2007 | 62 | 0.270 |
Why?
|
Electric Stimulation | 2 | 2023 | 1740 | 0.250 |
Why?
|
Physical Therapy Modalities | 3 | 2021 | 533 | 0.240 |
Why?
|
Isometric Contraction | 1 | 2005 | 149 | 0.230 |
Why?
|
Paraplegia | 1 | 2005 | 161 | 0.230 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2024 | 195 | 0.220 |
Why?
|
Military Personnel | 3 | 2022 | 1261 | 0.220 |
Why?
|
Muscular Dystrophy, Duchenne | 3 | 2011 | 271 | 0.200 |
Why?
|
Autophagy | 3 | 2022 | 1349 | 0.200 |
Why?
|
Epigenesis, Genetic | 3 | 2023 | 3834 | 0.200 |
Why?
|
Disease Models, Animal | 4 | 2025 | 18344 | 0.200 |
Why?
|
Arm | 1 | 2005 | 591 | 0.190 |
Why?
|
Neural Stem Cells | 2 | 2021 | 895 | 0.190 |
Why?
|
Humans | 42 | 2025 | 767991 | 0.190 |
Why?
|
United States Department of Veterans Affairs | 1 | 2007 | 937 | 0.190 |
Why?
|
Injections, Intra-Articular | 1 | 2022 | 284 | 0.190 |
Why?
|
Caspases, Initiator | 1 | 2020 | 31 | 0.180 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2021 | 80 | 0.180 |
Why?
|
Mechanotransduction, Cellular | 2 | 2018 | 541 | 0.180 |
Why?
|
Contusions | 2 | 2012 | 78 | 0.170 |
Why?
|
Male | 26 | 2025 | 364641 | 0.170 |
Why?
|
Genomics | 1 | 2016 | 5925 | 0.170 |
Why?
|
Cells, Cultured | 5 | 2024 | 19017 | 0.160 |
Why?
|
Caspase 1 | 1 | 2020 | 227 | 0.160 |
Why?
|
Knee Injuries | 1 | 2024 | 495 | 0.160 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2022 | 1942 | 0.160 |
Why?
|
Cartilage | 1 | 2023 | 811 | 0.160 |
Why?
|
Contracture | 1 | 2021 | 236 | 0.160 |
Why?
|
Chloroquine | 1 | 2020 | 276 | 0.160 |
Why?
|
Vesicle-Associated Membrane Protein 3 | 3 | 2022 | 12 | 0.150 |
Why?
|
MicroRNAs | 2 | 2024 | 3804 | 0.150 |
Why?
|
Torsion, Mechanical | 1 | 2017 | 15 | 0.140 |
Why?
|
Recovery of Function | 2 | 2021 | 2981 | 0.140 |
Why?
|
Mammals | 1 | 2023 | 1136 | 0.140 |
Why?
|
Forelimb | 1 | 2017 | 116 | 0.140 |
Why?
|
Prescriptions | 2 | 2011 | 388 | 0.130 |
Why?
|
Peripheral Nervous System | 1 | 2017 | 151 | 0.130 |
Why?
|
Certification | 1 | 2020 | 420 | 0.130 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2018 | 3612 | 0.130 |
Why?
|
Dependovirus | 1 | 2021 | 720 | 0.130 |
Why?
|
Estrogens | 1 | 2023 | 1536 | 0.130 |
Why?
|
Signal Transduction | 6 | 2024 | 23642 | 0.120 |
Why?
|
Acyltransferases | 1 | 2017 | 306 | 0.120 |
Why?
|
Congresses as Topic | 1 | 2020 | 812 | 0.120 |
Why?
|
Transcription Factor RelA | 1 | 2016 | 252 | 0.120 |
Why?
|
Torque | 2 | 2005 | 132 | 0.120 |
Why?
|
Female | 19 | 2025 | 397113 | 0.110 |
Why?
|
Athletic Injuries | 1 | 2024 | 1245 | 0.110 |
Why?
|
Resilience, Psychological | 1 | 2022 | 807 | 0.110 |
Why?
|
Myostatin | 3 | 2012 | 129 | 0.110 |
Why?
|
Mitochondria, Muscle | 1 | 2014 | 172 | 0.110 |
Why?
|
Quadriceps Muscle | 1 | 2014 | 157 | 0.110 |
Why?
|
Mice, Inbred mdx | 1 | 2013 | 90 | 0.110 |
Why?
|
Fibrosis | 3 | 2017 | 2080 | 0.110 |
Why?
|
Leg Injuries | 1 | 2014 | 180 | 0.100 |
Why?
|
Bioengineering | 1 | 2013 | 101 | 0.100 |
Why?
|
Veterans | 1 | 2007 | 2669 | 0.100 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11930 | 0.100 |
Why?
|
Lipolysis | 1 | 2013 | 211 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2021 | 4289 | 0.100 |
Why?
|
Muscular Atrophy | 1 | 2014 | 335 | 0.100 |
Why?
|
Multiple Sclerosis | 1 | 2007 | 3250 | 0.100 |
Why?
|
Ischemia | 1 | 2020 | 1900 | 0.090 |
Why?
|
Central Nervous System Diseases | 1 | 2016 | 519 | 0.090 |
Why?
|
Genetic Vectors | 1 | 2021 | 3402 | 0.090 |
Why?
|
Artificial Limbs | 1 | 2013 | 121 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2018 | 1409 | 0.090 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1135 | 0.090 |
Why?
|
Losartan | 1 | 2012 | 262 | 0.090 |
Why?
|
Reactive Oxygen Species | 2 | 2020 | 2149 | 0.090 |
Why?
|
Environmental Pollutants | 1 | 2020 | 1296 | 0.090 |
Why?
|
Robotics | 1 | 2017 | 813 | 0.090 |
Why?
|
Transduction, Genetic | 2 | 2010 | 899 | 0.090 |
Why?
|
Burns | 1 | 2021 | 1899 | 0.080 |
Why?
|
Electrodes | 1 | 2012 | 617 | 0.080 |
Why?
|
Stem Cell Niche | 1 | 2013 | 347 | 0.080 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3428 | 0.080 |
Why?
|
Suramin | 1 | 2008 | 34 | 0.080 |
Why?
|
beta-Galactosidase | 1 | 2010 | 574 | 0.080 |
Why?
|
Biomedical Research | 1 | 2024 | 3463 | 0.080 |
Why?
|
Hindlimb Suspension | 1 | 2009 | 76 | 0.080 |
Why?
|
Age Factors | 2 | 2021 | 18407 | 0.080 |
Why?
|
Action Potentials | 1 | 2015 | 1841 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2017 | 2450 | 0.070 |
Why?
|
Urinary Bladder | 1 | 2014 | 1157 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5798 | 0.070 |
Why?
|
Oxidative Phosphorylation | 2 | 2020 | 501 | 0.070 |
Why?
|
Mice, SCID | 1 | 2012 | 2627 | 0.070 |
Why?
|
Cell Proliferation | 5 | 2020 | 10470 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2020 | 14486 | 0.070 |
Why?
|
Parkinson Disease | 1 | 2021 | 2893 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2906 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3782 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1893 | 0.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2022 | 605 | 0.060 |
Why?
|
Stroke | 2 | 2021 | 9755 | 0.060 |
Why?
|
Diffusion of Innovation | 1 | 2010 | 724 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2473 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1247 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3443 | 0.060 |
Why?
|
Central Nervous System | 1 | 2013 | 1346 | 0.060 |
Why?
|
Glycolysis | 2 | 2020 | 837 | 0.060 |
Why?
|
Aminopropionitrile | 1 | 2024 | 9 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20218 | 0.060 |
Why?
|
DNA Methylation | 1 | 2018 | 4426 | 0.060 |
Why?
|
Proteoglycans | 1 | 2007 | 809 | 0.060 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2009 | 507 | 0.060 |
Why?
|
Oncostatin M | 1 | 2023 | 42 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4258 | 0.060 |
Why?
|
Shoulder Pain | 1 | 2005 | 152 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 638 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 1 | 2007 | 832 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2014 | 3140 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2012 | 2029 | 0.050 |
Why?
|
Shoulder | 1 | 2005 | 300 | 0.050 |
Why?
|
Cell Line | 4 | 2021 | 15597 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Kinetics | 1 | 2010 | 6328 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3929 | 0.050 |
Why?
|
Phenotype | 2 | 2023 | 16723 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 30260 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9493 | 0.050 |
Why?
|
Collagen | 1 | 2010 | 2641 | 0.050 |
Why?
|
Forecasting | 1 | 2010 | 2945 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3329 | 0.050 |
Why?
|
Adult | 8 | 2024 | 223583 | 0.050 |
Why?
|
Cell Lineage | 1 | 2010 | 2574 | 0.050 |
Why?
|
Neurosecretory Systems | 1 | 2022 | 223 | 0.040 |
Why?
|
Therapies, Investigational | 1 | 2021 | 110 | 0.040 |
Why?
|
Research | 1 | 2009 | 1979 | 0.040 |
Why?
|
Muscle Cells | 1 | 2020 | 195 | 0.040 |
Why?
|
Follistatin | 2 | 2012 | 138 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2007 | 1996 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14783 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2014 | 4543 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3701 | 0.040 |
Why?
|
Carbonic Anhydrases | 1 | 1999 | 108 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 866 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3514 | 0.040 |
Why?
|
Acids | 1 | 2018 | 125 | 0.040 |
Why?
|
Range of Motion, Articular | 1 | 2005 | 1597 | 0.040 |
Why?
|
Shoulder Joint | 1 | 2005 | 745 | 0.040 |
Why?
|
Cell Movement | 1 | 2010 | 5209 | 0.040 |
Why?
|
Young Adult | 4 | 2024 | 60048 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2018 | 297 | 0.040 |
Why?
|
Transcription Factors | 1 | 2017 | 12165 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36742 | 0.030 |
Why?
|
Extracellular Space | 1 | 2018 | 563 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2022 | 1027 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1074 | 0.030 |
Why?
|
Rats | 3 | 2021 | 23751 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2708 | 0.030 |
Why?
|
Explosive Agents | 1 | 2014 | 26 | 0.030 |
Why?
|
Biomimetic Materials | 1 | 2016 | 173 | 0.030 |
Why?
|
Neurons | 1 | 2013 | 9518 | 0.030 |
Why?
|
Tensile Strength | 1 | 2014 | 332 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2650 | 0.030 |
Why?
|
Receptor, Endothelin A | 1 | 2013 | 55 | 0.030 |
Why?
|
Afghan Campaign 2001- | 1 | 2014 | 298 | 0.030 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2014 | 225 | 0.030 |
Why?
|
Cell Death | 1 | 2018 | 1679 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2020 | 1369 | 0.030 |
Why?
|
Rabbits | 1 | 2018 | 4771 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1880 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2018 | 1311 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2014 | 412 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2020 | 2456 | 0.020 |
Why?
|
Ultrasonography | 1 | 2024 | 6004 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2014 | 1049 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4351 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10627 | 0.020 |
Why?
|
Exercise Test | 1 | 2017 | 2186 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8314 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1892 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2020 | 1304 | 0.020 |
Why?
|
Weight-Bearing | 1 | 2011 | 534 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3522 | 0.020 |
Why?
|
Postoperative Care | 1 | 2014 | 1480 | 0.020 |
Why?
|
Decorin | 1 | 2007 | 38 | 0.020 |
Why?
|
Motor Activity | 1 | 2017 | 2711 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9536 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7450 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 554 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2005 | 22287 | 0.020 |
Why?
|
Middle Aged | 3 | 2007 | 223422 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4576 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 7072 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2007 | 668 | 0.020 |
Why?
|
Preoperative Care | 1 | 2014 | 2256 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2022 | 7876 | 0.020 |
Why?
|
Hippocampus | 1 | 2017 | 3786 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9521 | 0.010 |
Why?
|
Swine | 1 | 2014 | 5994 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8535 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10871 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 12797 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3813 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2007 | 59598 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 2936 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10757 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8748 | 0.010 |
Why?
|
Hexosephosphates | 1 | 1999 | 24 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54924 | 0.010 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 1999 | 92 | 0.010 |
Why?
|
United States | 1 | 2007 | 73027 | 0.010 |
Why?
|
Muscle Fatigue | 1 | 1999 | 96 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2007 | 81746 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6515 | 0.010 |
Why?
|
Brain | 1 | 2023 | 27366 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2009 | 11068 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1999 | 1888 | 0.010 |
Why?
|
Aged | 1 | 2007 | 171446 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 89155 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1999 | 2678 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 24314 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39345 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 40214 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 65364 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 13658 | 0.000 |
Why?
|